Author:
Masrani Nanang,Dewi Ni N. A.,Linawati Ni M.,Ekawati Ni P.,Mulyawan I Made
Abstract
The majority of colorectal cancer (CRC) are sporadic CRC that can be caused by genetic variations such as Single Nucleotide Polymorphisms (SNPs). The CCND1 gene polymorphism rs9344 could involve at the beginning and the development of CRC. This study aimed to analyze the association between CCND1 gene polymorphism rs9344 with the grade and invasion degree of colorectal cancer in at Prof. Dr. I.G.N.G. Ngoerah Central General Hospital, Denpasar, Bali. This cross-sectional study was carried out at the Integrated Biomedical Laboratory Unit, Faculty of Medicine, Udayana University. Data analysis of 32 samples showed majority age was above 50 years old as many as 28 (87.5%), with men as 21 samples (65.6%). Histopathology description was adenocarcinoma in 32 samples (100%). Grading histopathology low grade was 31 samples (96.6%). The degree of tumor invasion was high as 25 samples (78.1%). From the aspect of pathological stage pNx as much as 27 (84.4%). The majority location of tumors was on the left side as 21 samples (65.6%). The polymorphisms of CCND1 rs9344 genotype sequentially AA as 20 samples (62.5%), AG as 9 samples (28.1%), while GG as 3 samples (9.4%). The statistical analysis found that CCND1 gene polymorphism rs9344 was not associated with colorectal cancer grade (p>0.05), and not associated with invasion degrees of colorectal cancer (p>0.05). Taken together, we conclude that no significant association between the CCND1 gene polymorphism rs9344 with grade and invasion degree of colorectal cancer at Prof. Dr. I.G.N.G. Ngoerah Central General Hospital, Denpasar, Bali.
Publisher
European Open Science Publishing
Reference41 articles.
1. WHO. Classification of tumours 5th edition digestive system tumours [Internet]. 2019. [cited 2022 Oct 22]. Available from: https://dokumen.pub/who-classification-of-tumours-5th-edition-digestive-system-tumours-1-5nbsped-9789283244998.html#WHO+Classification+of+Tumours+Editorial+Board.
2. Ni Nyoman AD, Suksmarini NMPW, Pranata AANS, Rompis AY, Sumadi IWJ. The prevalence of KRAS and BRAF mutation in colorectal cancer patients in Bali. Indones J Biotechnol [Internet]. 2022 Mar; 29;27(1):29. Available from: https://jurnal.ugm.ac.id/ijbiotech/article/view/67506.
3. Xie M, Zhao F, Zou X, Jin S, Xiong S. The association between CCND1 G870A polymorphisms and colorectal cancer risk. Medicine (Baltimore) [Internet]. 2017; Oct;96(42): e8269. Available from: https://journals.lww.com/00005792-201710200-00058.
4. Chauhan P, Kaur P sahib, Babu AM. CYCLIN D1: As a Risk of Breast Cancer. CGC Int J Contemp Technol Res [Internet]. 2020 Dec; 26;3(1):134–8. Available from: https://cgcijctr.com/document/C0301105-FINAL.pdf.
5. Wen J, Xu Q, Yuan Y. Single nucleotide Polymorphisms and sporadic colorectal cancer susceptibility: A field synopsis and meta-analysis. Cancer Cell Int. 2018;18(1).